20/20 BIOLABS INC (AIDX) Stock Price & Overview

NASDAQ:AIDX • US90138K1016

Current stock price

1.71 USD
-0.07 (-3.93%)
At close:
1.719 USD
+0.01 (+0.53%)
After Hours:

The current stock price of AIDX is 1.71 USD. Today AIDX is down by -3.93%. In the past month the price decreased by -15.43%.

AIDX Key Statistics

1-Month Range1.51 - 2.1004
Current AIDX stock price positioned within its 1-month range.
Market Cap
17.921M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
N/A
Dividend Yield
N/A

AIDX Stock Performance

Today
-3.93%
1 Week
-7.57%
1 Month
-15.43%
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

AIDX Stock Chart

20/20 BIOLABS INC / AIDX Daily stock chart

AIDX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AIDX.


Chartmill TA Rating
Chartmill Setup Rating

AIDX Earnings

Next Earnings DateN/A
Last Earnings DateN/A

AIDX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AIDX Groups

Sector & Classification

Index Membership

AIDX Financial Highlights


Income Statements
Revenue(TTM)N/A
Net Income(TTM)N/A
Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

AIDX Ownership

Ownership
Inst OwnersN/A
Shares10.48M
Float7.30M
Ins Owners17.05%
Short Float %0.75%
Short Ratio0.14

About AIDX

Company Profile

AIDX logo image 20/20 Biolabs Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Rockville, Maryland. 20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.

Company Info

IPO: 2021-09-08

20/20 BIOLABS INC

9430 Key West Avenue, Suite 100

Rockville MARYLAND US

Employees: 0

AIDX Company Website

Phone: 12404536339

20/20 BIOLABS INC / AIDX FAQ

What does 20/20 BIOLABS INC do?

20/20 Biolabs Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Rockville, Maryland. 20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.


Can you provide the latest stock price for 20/20 BIOLABS INC?

The current stock price of AIDX is 1.71 USD. The price decreased by -3.93% in the last trading session.


Does 20/20 BIOLABS INC pay dividends?

AIDX does not pay a dividend.


What is the ChartMill rating of 20/20 BIOLABS INC stock?

AIDX has a ChartMill Technical rating of 1 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.


Where is 20/20 BIOLABS INC (AIDX) stock traded?

AIDX stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of AIDX stock?

20/20 BIOLABS INC (AIDX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of AIDX stock?

20/20 BIOLABS INC (AIDX) has a market capitalization of 17.92M USD. This makes AIDX a Nano Cap stock.